Module

Immune Control and Immune Failure in HIV Infection

Source: HIV/AIDS Annual Update 2006

Immune Control and Immune Failure in HIV Infection


CME Program Director: John P. Phair, MD

Faculty:

  • Bruce D. Walker, MD

CME CREDIT INFORMATION

Release Date: 06/30/06

Expiration Date: 06/29/07


Physicians: maximum of 1.0 AMA PRA Category 1 Credit(s)

Pharmacists: 1.0 contact hour (0.1 CEUs)

Registered Nurses: 1.1 Nursing CE credits

Status: Please log in to view status



Learning Objectives

Upon completion of this activity, participants should be able to:

  • Describe the immune correlates of HIV infection and disease progression
  • Explain the process of viral adaptation to the host immune response in HIV infection
  • Outline prospects for the development of immunotherapy in HIV infection

Topics covered include:

  • Introduction
  • Immune Correlates of Disease Progression
  • Reasons for Immune Failure in HIV Disease
  • Prospects for Immunotherapy
  • Conclusions
  • Summary—Implications for Clinical Practice


Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.

Jointly sponsored by Postgraduate Institute for Medicine and Clinical Care Options, LLC.

Educational grants provided by:

Educational grants support only the CME-certified components of this program.